Baylac-Domengetroy F, Baylac-Domengetroy J, Chaix A F, Elbaz-Rostykus C, Barraine R
Service de cardiologie A, CHU la Milétrie, Poitiers.
Arch Mal Coeur Vaiss. 1990 Jul;83(8):1295-9.
We have realized an unicentric prospective study to assess the effects of Nitrendipine on carotid circulation and arterial blood pressure (BP) in essential, permanent, uncomplicated arterial hypertension. This randomized, double blind versus placebo trial concerned 21 mild to moderate hypertensive patients (pts) (WHO advices) aged from 35 to 65 years. After a 15 days washout, the pts were randomized in two groups: 11 pts received a 20 mg Nitrendipine tablet once a day and 10 pts received a placebo. BP control and ultrasonic carotid flowmetry were performed at J0 and J30. At J30, BP was normalized for 55% of pts under NT (versus 30% for placebo). This result correspond to a very significative decrease for systolic and diastolic BP and differential BP (Dif BP) without reflex tachycardia, under Nitrendipine, opposite to placebo. Ultrasonic carotid flowmetry variations are not significative excepting common carotid vasodilation under Nitrendipine. Under Nitrendipine, at J30, 5 pts show a decrease of a least 15% of the cerebral vascular resistances (responding patients); and 6 pts do not show any significative decrease of cerebral vascular resistances. For the responding pts, arteriolar vasodilation is then correlated to the decrease of BP and Dif BP, to the increase of carotid blood flow and to the arterial vasodilation; while there is no significative decrease of BP for non responding pts. It suggests an improvement of arterial compliance by a direct action on the arterial wall. Furthermore, inspite of a drop in diastolic parietal tension, there is not any group showing reflex tachycardia. Thus, antihypertensive efficacy of Nitrendipine seem to be principally subordinated to the improvement of arterial compliance.(ABSTRACT TRUNCATED AT 250 WORDS)
我们开展了一项单中心前瞻性研究,以评估尼群地平对原发性、持续性、无并发症动脉高血压患者颈动脉循环和动脉血压(BP)的影响。这项随机、双盲、安慰剂对照试验涉及21例年龄在35至65岁之间的轻至中度高血压患者(符合世界卫生组织标准)。经过15天的洗脱期后,患者被随机分为两组:11例患者每天服用一次20毫克尼群地平片,10例患者服用安慰剂。在第0天和第30天进行血压控制和颈动脉超声血流测定。在第30天,接受尼群地平治疗的患者中55%血压恢复正常(安慰剂组为30%)。这一结果表明,与安慰剂相比,尼群地平可使收缩压、舒张压和脉压差(Dif BP)显著降低,且无反射性心动过速。除尼群地平治疗下颈总动脉血管舒张外,颈动脉超声血流测定的变化无统计学意义。在尼群地平治疗下,第30天时,5例患者脑血管阻力至少降低15%(有反应患者);6例患者脑血管阻力无显著降低。对于有反应的患者,小动脉血管舒张与血压和脉压差的降低、颈动脉血流量的增加以及动脉血管舒张相关;而无反应患者的血压无显著降低。这表明尼群地平通过直接作用于动脉壁改善了动脉顺应性。此外,尽管舒张压壁张力有所下降,但两组均未出现反射性心动过速。因此,尼群地平的降压疗效似乎主要取决于动脉顺应性的改善。(摘要截选至250字)